在PTEN-null前列腺中,PLEKHS1驱动PI3Ks并重塑途径平衡
Tamara A M Chessa1, Piotr Jung1, Arqum Anwar1
1Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Molecular cell
|August 11, 2023
概括
在PTEN-null前列腺癌中,PLEKHS1适配蛋白通过逃避反和促进AKT酸化来驱动过度活跃的PIP3/PI3K信号,从而支持瘤生长.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 酸3-酶 (PI3K) 网络调节新陈代谢,在癌症中经常过度激活,通常是由于PTEN酸酶的损失.
- 了解正常组织中PI3K网络的驱动因素及其适应过度激活对于癌症研究至关重要.
研究的目的:
- 调查驱动PI3K活动的信号网络在健康和PTEN-null小鼠前列腺中.
- 为了确定关键的分子参与者和机制,负责持续PI3K通路激活在没有PTEN的情况下.
主要方法:
- 在小鼠前列腺模型中分析PI3K网络信号.
- 蛋白质-蛋白质相互作用和翻译后修改的识别和表征.
- 在人类前列腺癌样本中对分子标记物与PI3K通路活性进行相关性分析.
主要成果:
- 在健康的小鼠前列腺中,PI3K活性通过RTK/IRS信号和反抑制来调节.
- 在PTEN-null前列腺中,适应蛋白PLEKHS1成为PI3K网络的主导激活剂.
- 通过逃避反,PLEKHS1维持了PIP3水平和AKT酸化,并通过PI3K和Src家族激酶驱动的YXXM基因进行增强酸化.
结论:
- 在PTEN缺陷前列腺癌中,PLEKHS1充当PI3K通路激活的关键调解者.
- 对PLEKHS1的受体独立,Src依赖酸化会产生一个积极的反循环,推动瘤的进展.
- PLEKHS1和Src激活是人类前列腺癌中具有PI3K通路激活的潜在生物标志物和治疗标.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K


